Advertisement

Somatostatin pp 403-423 | Cite as

Pancreatic Somatostatin

  • Gordon C. Weir
  • Susan Bonner-Weir
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 188)

Abstract

This is a review of pancreatic somatostatin which is limited in its scope and therefore focuses upon some selected issues. Throughout the entire review the same basic questions recur: Why do islets contain somatostatin? What is the physiological role of somatostatin and what does this peptide have to do with diabetes? Clear answers to these questions do not emerge, but a number of hunches are explored. The review provides a very brief look at somatostatin secretion, a discussion of the potential interactions which islet D cells might have with other islet cell types, consideration of how knowledge of islet anatomy may help us understand the D cell, and finally some comments about what happens to the D cell in diabetes and fasting.

Keywords

Glucagon Secretion Glucagon Release Intact Islet Perfuse Pancreas Islet Cell Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weir GC, Goltsos PC, Steinberg EP, Patel YC 1976 High concen- tration of somatostatin immunoreactivity in chicken pancreas. Diabetologia 12: 129.PubMedCrossRefGoogle Scholar
  2. 2.
    Ronner P, Scarpa A 1982 Isolated perfused Brockmann body as a model for studying pancreatic endocrine secretion. Am J Physiol 243: 352.Google Scholar
  3. 3.
    Orci L, Baetens D, Ravazzola M, Stefan Y, Malaisse-Lagae F 1976 Pancreatic polypeptide and glucagon: non-random distribution in pancreatic islets. Life Sci 19: 1811.PubMedCrossRefGoogle Scholar
  4. 4.
    Samols E, Weir G,Bonner-Weir S 1983 Intraislet insulinglucagon-somatostatin relationships. In: Lefebvre P (ed) Handbook of Experimental Pharmacology 66/II. Springer-Verlag, Berlin.Google Scholar
  5. 5.
    Gerber PPG, Trimble ER, Woiheim CB, Renold AE 1981 Effect of insulin on glucose-and arginine-stimulated somatostatin secretion from the isolated perfused rat pancreas. Endocrinology 109: 279.PubMedCrossRefGoogle Scholar
  6. 6.
    Kawai K, Unger RH 1983 Opposing actions of glucagon and insulin on splanchnic D cell function. J Clin Invest 71: 721.PubMedCrossRefGoogle Scholar
  7. 7.
    Honey RN, Weir GC 1979 Insulin stimulates somatostatin and inhibits glucagon secretion from the perfused chicken pancreas-duodenum. Life Sci 24: 1747.PubMedCrossRefGoogle Scholar
  8. 8.
    Iversen J, Miles DW 1971 Evidence for a feedback inhibition of insulin on insulin secretion in the isolated perfused canine pancreas. Diabetes 20: 1.PubMedGoogle Scholar
  9. 9.
    Ipp E, Rivier J, Dobbs RE, Brown M, Vale W, Unger RH 1979 Somatostatin analogs inhibit somatostatin release. Endocrinology 104: 1270.PubMedCrossRefGoogle Scholar
  10. 10.
    Kawai K, Unger RH 1982 Inhibition of glucagon secretion by exogenous glucagon in the isolated perfused dog pancreas. Diabetes 31: 512.PubMedCrossRefGoogle Scholar
  11. 11.
    Samols E, Weir GC 1979 Adrenergic modulation of pancreatic A, B, and D cells: alpha-adrenergic suppression and betaadrenergic stimulation of somatostatin secretion, alphaadrenergic stimulation of glucagon secretion in the perfused dog pancreas. J Clin Invest 63: 230.PubMedCrossRefGoogle Scholar
  12. 12.
    Samols E, Stagner JI, Weir GC 1981 Autonomic function and control of pancreatic somatostatin. Diabetologia 20: 388.PubMedCrossRefGoogle Scholar
  13. 13.
    Palmer JP, Porte D 1981 Control of glucagon secretion: the central nervous system. In: Unger RH, Orci L (eds) Glucagon: Physiology, Pathophysiology and Morphology of the Pancreatic A-cells. Elsevier, New York, p 135.Google Scholar
  14. 14.
    Saito A, Williams JA, Kanno T 1980 Potentiation of cholecystokinin-induced exocrine secretion by both exogenous and endogenous insulin in isolated and perfused rat pancreata. J Clin Invest 65: 777.PubMedCrossRefGoogle Scholar
  15. 15.
    Bonner-Weir S, Orci L 1982 New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31: 883.PubMedCrossRefGoogle Scholar
  16. 16.
    Samols E, Harrison J 1976 Remarkable potency of somatostatin as a glucagon suppressant. Metabolism 25 (suppl. 1): 1495.PubMedCrossRefGoogle Scholar
  17. 17.
    Kawai K, Orci L, Ipp E, Perrelet A, Unger RH 1982 Circulating somatostatin acts on the islets of Langerhans via a somatostatin-poor compartment. Science 218: 477.PubMedCrossRefGoogle Scholar
  18. 18.
    Weir GC, Samols E, Day JA, Patel YC 1978 Glucose and glucagon stimulate secretion of somatostatin from the perfused canine pancreas. Metabolism 27: 1223.PubMedCrossRefGoogle Scholar
  19. 19.
    Weir GC, Halban PA, Meda P, Wollheim B, Orci L, Renold AE 1984 Dispersed adult rat pancreatic islet cells in culture: A, B, and D cell function. Metabolism 33: 447.Google Scholar
  20. 20.
    Bonner-Weir S 1984 Morphological evidence for B-cell polarity within the islet of Langerhans in the rat. Diabetes 33: (suppl. 1): 81A.CrossRefGoogle Scholar
  21. 21.
    Fujita T 1967 D cell, the third endocrine element of the pancreatic islet. Arch Histol Jap 29: 1.Google Scholar
  22. 22.
    Leiter EH, Gapp DA, Eppig JJ, Coleman DL 1979 Ultrastructure and morphometric studies of delta cells in pancreatic islets from C57BL/KsJ diabetes mice. Diabetes 17: 297.Google Scholar
  23. 23.
    Orci L, Malaisse-Lagae F, Ravazzola M, Rouiller D, Renold AE, Perrelet A, Unger R 1975 A morphological basis for intercellular communication between ct-and (3-cells in the endocrine pancreas. J Clin Invest 56: 1066.PubMedCrossRefGoogle Scholar
  24. 24.
    Meda P, Perelet A, Orci L 1980 Gap junctions and B cell function. Horm Metab Res 10 (suppl.): 157.Google Scholar
  25. 25.
    Fletcher DJ, Grogan W, Barras E, Weir GC 1983 Hormone release by islet B cell-enriched and A and D cell-enriched populations prepared by flow cytometry. Endocrinology 113: 1791.PubMedCrossRefGoogle Scholar
  26. 26.
    Meda P, Sorenson R, Sheridan JD 1983 Perturbation of B-cell coupling in diabetic rat islets. Diabetes 32 (suppl. 1): 41A.Google Scholar
  27. 27.
    Saito K, Yaginuma N, Takahashi T 1979 Differential volumetry of A, B, and D cells in the pancreatic islets of diabetic and non-diabetic subjects. Tohoku J Exp Med 129: 273.Google Scholar
  28. 28.
    Bonner-Weir S, Trent DF, Honey RN, Weir GC 1981 Responses of neonatal rat islets to streptozotocin: Limited B-cell regeneration and hyperglycemia. Diabetes 30: 64.Google Scholar
  29. 29.
    Weir GC, Clore ET, Zmachinski CJ, Bonner-Weir S 1981 Islet secretion in a new experimental model for non-insulin dependent diabetes. Diabetes 30: 590.PubMedCrossRefGoogle Scholar
  30. 30.
    Leahy JL, Weir GC 1984 Blindness to glucose in an experimental model of NIDDM: Inappropriate insulin and glucagon responses to glucose reduction. Clin Res 32: 521A.Google Scholar
  31. 31.
    Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Böhlen P, Esch F, Guillemin R 1981 Selective effects of somatostatin-14, -25, and -28 on in vitro insulin and glucagon secretion. Nature 291: 76.PubMedCrossRefGoogle Scholar
  32. 32.
    Taniguchi H, Utsumi M, Hasegawa M, Kobayashi T, Watanabe Y, Murakami K, Seki M, Tsutsu A, Makimura H, Sakoda M, Baba S 1977 Physiological role of somatostatin: Insulin release from rat islets treated by somatostatin antiserum. Diabetes 26: 700.Google Scholar
  33. 33.
    Itoh M, Mandarino L, Gerich JE 1980 Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: Evidence for a physiological role for endogenous somatostatin in the regulation of pancreatic A and B cell function. Diabetes 29: 693.Google Scholar
  34. 34.
    Pipeleers DG, Pipeleers-Marichal MA 1981 A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia 20: 654.Google Scholar
  35. 35.
    Pipeleers D, Veld P, Maes E, VanDeWinkel M 1982 Glucose-induced insulin release depends on functional cooperation between islet cells. Proc Natl Acad Sci (USA) 79: 7322.CrossRefGoogle Scholar
  36. 36.
    Trimble ER, Halban PA, Wollheim CB, Renold AE 1982 Functional differences between rat islets of ventral and dorsal pancreatic origin. J Clin Invest 69: 405.PubMedCrossRefGoogle Scholar
  37. 37.
    Samols E, Stagner J 1983 Dynamic differences in insulin secretion by the canine splenic and uncinate lobes. Diabetes 32 (suppl.): 41A.Google Scholar
  38. 38.
    Leclerq-Meyer V, Marchand J, Malaisse WJ 1983 Insulin and glucagon release by the perfused ventral and dorsal parts of the rat pancreas. Diabetologia 25: 175.Google Scholar
  39. 39.
    Sussman KE, Draznin B, Leitner JW, •Jehler PS 1982 The endocrine secretion granule revisited-postulating new functions. Metabolism 31: 959.PubMedCrossRefGoogle Scholar
  40. 40.
    Lefebvre PJ, Luyckx S 1978 Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology 103: 1579.PubMedCrossRefGoogle Scholar
  41. 41.
    Goto Y, Note S, Berelowitz •1, Frohman LA 1983 Somatostatin secretion from the isolated perfused rat pancreas or stomach. In: Mngola EN (ed) Diabetes. Excerpta Medica, Amsterdam.Google Scholar
  42. 42.
    Asplin CM, Paquette TL, Palmer JP 1981 In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest 68: 314.PubMedCrossRefGoogle Scholar
  43. 43.
    Stagner J, Samols E 1982 Differential glucagon and insulin release from the isolated lobes of the in vitro canine pancreas. Diabetes 31 (suppl. 2): 39A.Google Scholar
  44. 44.
    Gerich J, Langlois M, Noacco C, Karam J, Forsham P 1973 Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect. Science 182: 171.PubMedCrossRefGoogle Scholar
  45. 45.
    Bolli G, De Feo P, Perriello G, De Cosmo S, Compagnucci P, Santeusanio F, Brunetti P, Unger RH 1984 Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest 73: 917.Google Scholar
  46. 46.
    Hisatomi A, Maruyama H, Stake A, Vasko H, Orci L, Grodsky GM, Unger RH 1984 Mechanisms of the glucagon (IRG) response to hypoglycemia and its loss in diabetes. Diabetes 33 (suppl. 1): 79A.Google Scholar
  47. 47.
    Starke A, McGarry JD, Unger RH 1984 Evidence for direct glucose response by alpha cells and its attenuation by hyperglycemia. Diabetes 33 (suppl. 1): 80A.Google Scholar
  48. 48.
    Hermansen K, Schmitz 0, Orskov H 1984 Reversal of D and A cell insensitivity to glucose in alloxan diabetic dogs by treatment with the artificial beta cell (Biostator). Diabetes 33 (suppl. 1): 81A.CrossRefGoogle Scholar
  49. 49.
    Trimble ER, Gerber PPG, Renold AE 1981 Abnormalities of pancreatic somatostatin secretion corrected by in vivo insulin treatment of streptozotocin-diabetic rats. Diabetes 30: 365.CrossRefGoogle Scholar
  50. 50.
    Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH 1984 Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 74: 2296.PubMedCrossRefGoogle Scholar
  51. 51.
    Samols E, Weir GC, Ramseur R, Day.JA, Patel YC 1978 Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper-and hypoglycemic sulfonamides. Metabolism 27 (suppl. 1): 1219.Google Scholar
  52. 52.
    Efendic S, Enzmann F, Nylen A, Uvnäs-Wallensten K, Luft R 1980 Sulphonylurea ( Glibenclamide) enhances somatostatin and inhibits glucagon release induced by arginine. Acta Physiol Scand 108: 231.Google Scholar
  53. 53.
    Ipp E, Dobbs RE, Unger RH 1978 Morphine and 1S-endorphin influence the secretion of the endocrine pancreas. Nature 276: 190.PubMedCrossRefGoogle Scholar
  54. 54.
    Weir GC, Schwarz JA, Mathe CJ 1980 Inhibition of glucagon and insulin secretion from the perfused rat pancreas by a B cell-selective somatostatin analog. Metabolism 29: 68.PubMedCrossRefGoogle Scholar
  55. 55.
    Taborsky G 1983 Evidence of a paracrine role for pancreatic somatostatin in vivo. Am J Physiol 245: E598.PubMedGoogle Scholar
  56. 56.
    Honey RN, Arimura A, Weir GC 1981 Somatostatin neutralization stimulates glucagon and insulin secretion from the avian pancreas. Endocrinology 109: 1971.PubMedCrossRefGoogle Scholar
  57. 57.
    Gerich J, Lovinger R, Grodsky G 1975 Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: Evidence for a preferential effect on glucagon secretion. Endocrinology 96: 749.Google Scholar
  58. 58.
    Patel YC, Weir GC 1976 Increased somatostatin content of islets from streptozotocin-diabetic rats. Clin Endocrinol 5: 191.CrossRefGoogle Scholar
  59. 59.
    Patel YC, Cameron DP, Bankier A, Malaisse-Lagae F, Ravazzola M, Studer P, Orci L 1978 Changes in somatostatin concentration in pancreas and other tissues of streptozotocin diabetic rats. Endocrinology 103: 917.PubMedCrossRefGoogle Scholar
  60. 60.
    McEvoy RC, Hegre OD 1977 Morphometric quantitation of the pancreatic insulin-, glucagon-, and somatostatin-positive cell populations in normal and alloxan diabetic rats. Diabetes 26: 1140.PubMedCrossRefGoogle Scholar
  61. 61.
    Hara H, Patton G, Gerich J 1979 Increased somatostatin release from pancreases of alloxan diabetic rats perfused in vitro. Life Sci 24: 625.PubMedCrossRefGoogle Scholar
  62. 62.
    Patel YC, Wheatley T, Zingg HH 1980 Increased blood somatostatin concentration in streptozotocin diabetic rats. Life Sci 27: 1563.PubMedCrossRefGoogle Scholar
  63. 63.
    Schusdziarra V, Dobbs RE, Harris V, Unger RH 1977 Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs. FEBS Lett 81: 69.PubMedCrossRefGoogle Scholar
  64. 64.
    Patel YC, Wheatley T, Malaisse-Lagae F, Orci L 1980 Elevated portal and peripheral blood concentration of immunoreactive somatostatin in spontaneously diabetic (BBL) Wistar rats: suppression with insulin. Diabetes 29: 757.PubMedCrossRefGoogle Scholar
  65. 65.
    Kadowaki S, Taminato T, Chiba T, Goto Y, Nozawa M, Seino Y, Matsukura S, Fujita T 1980 Reversal of the enhanced somatostatin release from the isolated, perfused diabetic rat pancreas after the amelioration of diabetes by whole pancreas transplantation. Diabetes 29: 742.PubMedCrossRefGoogle Scholar
  66. 66.
    Pagliara AS, Stillings SN, Haymond MW, Hover BA, Matschinsky FM 1975 Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats. J Clin Invest 55: 244.PubMedCrossRefGoogle Scholar
  67. 67.
    Weir GC, Atkins RF, Martin DB 1976 Glucagon secretion from the perfused rat pancreas following acute and chronic streptozotocin. Metabolism 25: 1519.PubMedCrossRefGoogle Scholar
  68. 68.
    Weir GC, Knowlton SD, Atkins RF, McKennan KX, Martin DB 1976 Glucagon secretion from the perfused pancreas of streptozotocintreated rats. Diabetes 25: 275.PubMedCrossRefGoogle Scholar
  69. 69.
    Hermansen K, Orskov H, Christensen SE 1979 Streptozotocin diabetes: A glucoreceptor dysfunction affecting D cells as well as B and A cells. Diabetologia 17: 385.Google Scholar
  70. 70.
    Patel YC, Ruggere D, Malaisse-Lagae F, Orci L 1983 Alterations in somatostatin and other islet functions in the spontaneously diabetic BB Wistar rat: Biochemical and morphological characterization. Metabolism 32 (suppl. 1): 28.Google Scholar
  71. 71.
    Ruggere MD, Patel YC 1984 Somatostatin, glucagon, and insulin secetion from perfused pancreas of BB rats. Am J Physiol 247: E221.PubMedGoogle Scholar
  72. 72.
    Boden G, Naji A, Barker CF, June V, Matschinsky FM 1983 Effect of spontaneous diabetes on hormone release in BB/Phi rats: Comparison between the isolated perfused pancreas/stomach/ duodenum/spleen and the isolated perfused pancreas. Endocrinology 112: 1777.Google Scholar
  73. 73.
    Bottazzo GF, Doniach D 1978 Islet-cell antibodies in diabetes mellitus. Evidence of an autoantigen common to all cells in the islets of Langerhans. Ric Clin Lab 8: 29.Google Scholar
  74. 74.
    Matsushima Y, Makino H, Kanatsuka A, Osegawa M, Kumagai A, Nishimura M, Tochino Y, Makino S 1982 Pancreatic somatostatin contents in spontaneously diabetic KK and non-obese diabetic ( NOD) mice. Horm Metab Res 14: 292.Google Scholar
  75. 75.
    Berelowitz M, Coleman DL, Frohman LA 1980 Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice. Diabetes 29: 717.PubMedCrossRefGoogle Scholar
  76. 76.
    Baetens D, Stefan Y, Ravazzola M, Malaisee-Lagae F, Coleman DL, Orci L 1978 Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 27: 1.PubMedCrossRefGoogle Scholar
  77. 77.
    Patel YC, Orci L, Bankier A, Cameron DP 1976 Decreased pancreatic somatostatin concentration in spontaneously diabetic mice. Endocrinology 99: 1415.PubMedCrossRefGoogle Scholar
  78. 78.
    Makino H, Matsushima Y, Kanatsuka A, Yamamoto M, Kumagai A, Nishimura M 1979 Changes in pancreatic somatostatin content in spontaneously diabetic mice, as determined by radioimmunoassay and immunohistochemical methods. Endocrinology 104: 243.PubMedCrossRefGoogle Scholar
  79. 79.
    Seino Y, Seino S, Takemura J, Tsuda K, Nishi S, Ishida H, Seno M, Usami M, Ikeda M, Imura H 1984 Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats. Endocrinology 114: 457.PubMedCrossRefGoogle Scholar
  80. 80.
    Seino S, Seino Y, Takemura J, Tsuda K, Kuzuya H, Ishikawa K, Shimazu T, Imura H 1981 Somatostatin, insulin, and glucagon secretion from isolated perfused pancreas of obese rats. Am J Physiol 241: E146.PubMedGoogle Scholar
  81. 81.
    Petersson B, Elde R, Efendic S, Hökfelt T, Johansson 0, Luft R, Cerasi E, Hellerstrom C 1977 Somatostatin in the pancreas, stomach and hypothalamus of the diabetic Chinese hamster. Diabetologia 13: 463.PubMedCrossRefGoogle Scholar
  82. 82.
    Trent DF, Schwalke MA, Weir GC 1984 Pancreatic and gut hormones during fasting: insulin, glucagon, somatostatin. Hormone Res 19: 70.PubMedCrossRefGoogle Scholar
  83. 83.
    Sorenson R, Grouse LH, Elde RP 1983 Cysteamine blocks somatostatin secretion without altering the course of insulin or glucagon release. A new model for the study of islet function. Diabetes 32: 377.Google Scholar
  84. 84.
    Kanatsuka A, Makino H, Osegawa M, Kasanuki J, Suzuki T, Yoshida S, Horie H 1984 Is somatostatin a true local inhibitory regulator of insulin secretion? Diabetes 33: 510.PubMedCrossRefGoogle Scholar
  85. 85.
    Fujita Y, Amemiya H, Matoba K, Yajima Y, Yamamoto N 1984 Is cysteamine a specific depletor of pancreatic somatostatin? Diabetes 33 (Suppl. 1): 152A.Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Gordon C. Weir
    • 1
  • Susan Bonner-Weir
    • 1
  1. 1.Department of Internal MedicineMedical College of VirginiaRichmondUSA

Personalised recommendations